
Add to Cart
Troponin I (cTnI) is a special protein of myocardial cells, which has the function of regulating the contraction of cardiac cells, and is widely used in the clinical detection of myocardial injury and unstable angina. After the onset of such patients, cTnI appeared early, lasted a long time, had the advantages of myocardial specificity and long diagnosis window period, which was the first indicator for the diagnosis of myocardial infarction
Detection range | sample size | Sample type | Test time |
0.1~50ng/mL | 60μl | Whole blood / serum / plasma | 15min |
See a doctor | Chest pain / tightness | |||
Medical history and physical examination | Suspected ACS (acute coronary syndrome) | |||
electrocardiogram | Persistent ST segment elevation | Abnormal St/T segment ↓ | ![]() | ECG normal ↓ |
Biochemical test | ↓Confirm | CTN was positive | Troponin CTN negative ×2 | |
Risk stratification | high-risk | Low risk | ||
diagnosis | STEMI in ST segment elevation myocardial infarction | NSTEMI of non ST segment elevation myocardial infarction | UA of unstable angina pectoris | |
treatment | Reperfusion | interventional therapy | Non interventional therapy |
Cardiology, emergency, laboratory, pediatrics, hematology, oncology, Nephrology, surgery, etc
Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.